Discovery of a non-peptide small molecule that selectively mimics the biological actions of calcitonin

Biochimica et Biophysica Acta - General Subjects

Volumn 1526, Issue 2, 2001, Pages 183-190

  Katayama, Toyoko ^a   Furuya, Mayumi ^a   Yamaichi, Kozo ^a   Konishi, Kyoko ^a   Sugiura, Namino ^a   Murafuji, Hidenobu ^a   Magota, Koji ^a   Saito, Masayuki ^a   Tanaka, Shoji ^a   Oikawa, Shinzo ^a  

^a SUNTORY LTD   (Japan)

Author keywords

Agonist; Calcitonin; cAMP; Hypocalcemic activity; Non peptide mimetic; SUN B8155

Indexed keywords

5 [1 N (2 AMINOPHENYL)ETHANIMIDOYL] 1,6 DIHYDROXY 4 METHYL 2(1H) PYRIDONE; CALCITONIN; CALCITONIN RECEPTOR; CYCLIC AMP; IODINE 125; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RELATED RECEPTOR; PYRIDONE DERIVATIVE; RECEPTOR; SALCATONIN; SUN B8155; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM BLOOD LEVEL; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SELECTIVITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR BLOCKING;

ANIMALS; BINDING, COMPETITIVE; CALCITONIN; CALCIUM; CELL LINE; CYCLIC AMP; GENETIC VECTORS; HUMANS; MODELS, CHEMICAL; MOLECULAR STRUCTURE; PYRIDINES; RATS; RECEPTORS, CALCITONIN; TRANSFECTION;

EID: 0035799653     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(01)00125-8     Document Type: Article

References (31)

1. Sexton P.M., Findlay D.M., Martin T.J. Calcitonin. Curr. Med. Chem. 6:1999;1067-1093.
2. Segre G.V., Goldring S.T. Receptors for secretin, calcitonin, parathyroid hormone(PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family. Trends. Endocrinol. Metab. 4:1993;309-314.
3. Horne W.C., Shyu J., Chakraborty M., Baron R. Signal transduction by calcitonin. Trends Endocrinol. Metab. 5:1994;395-401.
4. Suzuki H., Nakamura I., Takahashi N., Ikuhara T., Matsuzaki K., Isogai Y., Hori M., Suda T. Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts. Endocrinology. 137:1996;4685-4690.
5. Galante L., Joplin G.F., MacIntyre I., Woodhouse N.J.Y. The calcium lowering effect of synthetic human, porcine, and salmon calcitonin in patients with Paget's disease. Clin. Sci. 44:1973;605-610.
6. Williams C.P., Meachim G., Taylor W.H. Effect of calcitonin treatment on osteoclast counts in Paget's disease of bone. J. Clin. Pathol. 31:1978;1212-1217.
7. Silverman S.L. Calcitonin. Am. J. Med. Sci. 313:1997;13-16.
8. Yabuta M., Suzuki Y., Ohsuye K. High expression of a recombinant human calcitonin precursor peptide in Escherichia coli. Appl. Microbiol. Biotechnol. 42:1995;703-708.
9. K. Furukawa, K. Okuno, S. Onai, K. Sugimura, Y. Yoko-o, Y. Ishibashi, T. Ohshima, N. Tsuruoka, K. Magota, S. Tanaka, K. Ohsuye, Production of an α-amidating enzyme (α-AE) in recombinant CHO cells, in: S. Kaminogawa et al. (Eds.), Animal Cell Technology: Basic and Applied Aspects, Vol. 5, Kluwer Academic Publishers, Dordrecht, 1993, pp. 493-499.
10. Findlay D.M., Michelangeli V.P., Eisman J.A., Frampton R.J., Moseley J.M., MacIntyre I., Whitehead R., Martin T.J. Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines. Cancer Res. 40:1980;4764-4767.
11. Fukayama S., Bosma T.J., Goad D.L., Voelkel E.F., Tashjian A.H. Jr. Human parathyroid hormone (PTH)-related protein and human PTH comparative biological activities on human bone cells and bone resorption. Endocrinology. 123:1988;2841-2848.
12. Forrest S.M., Ng K.W., Findlay D.M., Michelangeli V.P., Livesey S.A., Partridge N.C., Zajac J.D., Martin T.J. Characterization of an osteoblast-like clonal cell line which responds to both parathyroid hormone and calcitonin. Calcif. Tissue Int. 37:1985;51-56.
13. Urlaub G., Chasin L.A. Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. Proc. Natl. Acad. Sci. USA. 77:1980;4216-4220.
14. Oikawa S., Inuzuka C., Kuroki M., Matsuoka Y., Kosaki G., Nakazato H. Cell adhesion activity of non-specific cross-reacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface: homophilic and heterophilic adhesion. Biochem. Biophys. Res. Commun. 164:1989;39-45.
15. Gorn A.H., Lin H.Y., Yamin M., Auron P.E., Flannery M.R., Tapp D.R., Manning C.A., Lodish H.F., Krane S.M., Goldring S.R. Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line. J. Clin. Invest. 90:1992;1726-1735.
16. Schipani E., Karga H., Karaplis A.C., Potts J.T., Kronenberg H.M., Abou-Samra A.B., Segre G.V., Juppner H. Identical complementary deoxyribonucleic acids encode a human renal and bone parathyroid hormone (PTH)/PTH-related peptide receptor. Endocrinology. 132:1993;2157-2165.
17. Nagahira K., Fukuda Y., Nasu T., Kawashima H., Noguchi C., Kurihara T., Oikawa S., Nakanishi T. Construction and expression of a mouse-human chimeric antibody against human tumor necrosis factor-α Immunol. Lett. 64:1998;139-144.
18. Kuestner R.E., Elrod R.D., Grant F.J., Hagen F.S., Kuijper J.L., Matthewes S.L., O'hara P.J., Sheppard P.O., Stroop S.D., Thompson D.L., Whitmore T.E., Findlay D.M., Houssami S., Sexton P.M., Moore E. Cloning and characterization of an abundant subtype of the human calcitonin receptor. Mol. Pharmacol. 46:1994;246-255.
19. Oikawa S., Inuzuka C., Kuroki M., Arakawa F., Matsuoka Y., Kosaki G., Nakazato H. A specific heterotypic cell adhesion activity between members of carcinoembryonic antigen family, W272 and NCA, is mediated by N-domains. J. Biol. Chem. 266:1991;7995-8001.
20. Frandsen E.K., Krishna G. A simple ultrasensitive method for the assay of cyclic AMP and cyclic GMP in tissues. Life Sci. 18:1976;529-541.
21. Beavo J.A., Rogers N.L., Crofford O.B., Hardman J.G., Sutherland E.W., Newman E.V. Effects of xanthine derivatives on lipolysis and on adenosine 3′,5′-monophosphate phosphodiesterase activity. Mol. Pharmacol. 6:1970;597-603.
22. George S.E., Bungay P.J., Naylor L.H. Functional coupling of endogenous serotonin (5-HT1B) and calcitonin (C1a) receptors in CHO cells to a cyclic AMP-responsive luciferase reporter gene. J. Neurochem. 69:1997;1278-1285.
23. Horie K., Insel P.A. Retrovirally mediated transfer of a G protein-coupled receptor kinase (GRK) dominant-negative mutant enhances endogenous calcitonin receptor signaling in Chinese hamster ovary cells. J. Biol. Chem. 275:2000;29433-29440.
24. Disa J., Dang K., Tan K.B., Aiyar N. Interaction of adrenomedullin with calcitonin receptor in cultured human breast cancer cells, T47D. Peptides. 19:1998;247-251.
25. Azria M., Copp D.H., Zanelli J.M. 25 Years of salmon calcitonin: from synthesis to therapeutic use. Calcif. Tissue Int. 57:1995;405-408.
26. Martin T.J. Calcitonin, an update. Bone. 24:1999;63S-65S.
27. Muff R., Dambacher M.A., Fischer J.A. Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of postmenopausal osteoporosis. Osteoporosis Int. 1:1991;72-75.
28. Ikegame M., Rakopoulos M., Martin T.J., Moseley J.M., Findlay D.M. Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor expression in mouse bone marrow cultures. J. Bone Miner. Res. 11:1996;456-465.
29. Stroop S.D., Kuestner R.E., Serwold T.F., Chen L., Moore E.E. Chimeric human calcitonin and glucagon receptors reveal two dissociable calcitonin interaction sites. Biochemistry. 34:1995;1050-1057.
30. Stroop S.D., Nakamuta H., Kuestner R.E., Moore E.E., Epand R.M. Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane-loop regions. Endocrinology. 137:1996;4752-4756.
31. Hirsch P.F., Voelkel E.F., Munson P.L. Thyrocalcitonin: Hypocalcemic hypophosphatemic principle of the thyroid gland. Science. 146:1964;412-413.